About the Annual Report
The resurgence of interest in peptide therapeutics in the biopharmaceutical industry has prompted the Peptide Therapeutics Foundation in collaboration with the Tufts Center for the Study of Drug Development (CCSD) to complete the first exhaustive survey on development trends for peptide therapeutics and insure annual updates going forward. This report is an invaluable decision making tool for senior executives in research, development, marketing, finance, and business development. The first report (2008 Edition) is now available for purchase through the Foundation. The proceeds of the commercialization will be used to commission future annual updates.

The 2008 Report reveals a marked increase in the number of peptide new chemical entities (NCEs) that have entered clinical development in recent years, an increase in size of peptides being developed, an evolution of manufacturing methods, an increased diversity of molecular targets and therapeutic areas and high development success rates, similar to biologics. Whereas there has been a significant increase in peptide NCEs approved in recent years for multiple indications including multiple sclerosis, osteoporosis, HIV or diabetes, late stage peptide R&D pipelines indicate that the trend will continue in coming years.